×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Budget 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Venus Remedies
Venus Remedies
Venus Remedies Consolidated September 2025 Net Sales at Rs 192.75 crore, up 15.11% Y-o-Y
Venus Remedies Standalone September 2025 Net Sales at Rs 192.65 crore, up 15.35% Y-o-Y
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
Stocks to Watch Today: MCX India, Oberoi Realty, Cipla, Venus Remedies, Dixon Technologies, L&T Finance in focus on 21 January
Venus Remedies shares rise 3% as Moldova GMP nod paves way for East Europe expansion
Venus Remedies bags Marketing Authorization in the Philippines for Chemotherapy agent
Venus Remedies Consolidated September 2024 Net Sales at Rs 167.45 crore, down 0.16% Y-o-Y
Venus Remedies Standalone September 2024 Net Sales at Rs 167.02 crore, down 1.86% Y-o-Y
Venus Remedies Consolidated June 2024 Net Sales at Rs 108.61 crore, up 14.15% Y-o-Y
Venus Remedies Standalone June 2024 Net Sales at Rs 105.86 crore, up 7.33% Y-o-Y
Venus Remedies Consolidated March 2024 Net Sales at Rs 195.16 crore, up 25.39% Y-o-Y
Venus Remedies Standalone March 2024 Net Sales at Rs 175.16 crore, up 17.93% Y-o-Y
Venus Remedies gets marketing authorisations for three cancer drugs from Ukraine
Venus Remedies Consolidated December 2023 Net Sales at Rs 143.42 crore, up 22.69% Y-o-Y
Venus Remedies Standalone December 2023 Net Sales at Rs 131.23 crore, up 19.9% Y-o-Y
Venus Remedies Standalone September 2023 Net Sales at Rs 170.19 crore, up 36.42% Y-o-Y
Venus Remedies gets UK approval for chemotherapy drugs
Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines
Venus Remedies gains 4% on Philippine nod to market 6 chemotherapy drugs
Venus Remedies trades 2% up on approval to market cancer drugs in Serbia
Venus Remedies gains on registering with govt body; to get custom duty exemption
Venus Remedies gets marketing approval for anticoagulant drug in Saudi Arabia
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio